| Literature DB >> 35208166 |
Éva Csöndör1,2, Gellért Karvaly1, Roland Ligetvári2, Krisztián Kovács1, Zsolt Komka3,4, Ákos Móra2, Tímea Stromájer-Rácz5, András Oláh5, Miklós Tóth1,3,5,6, Pongrác Ács5,6.
Abstract
Athletes are often exposed to extreme physical stress during training or competitions. The consequent activation of the hypothalamus-hypophysis-adrenal (HPA) axis results in intensified steroid hormone production in the adrenal cortex. We determined the impact of an acute extreme physical stress on adrenal and gonadal steroidogenesis in healthy male professional athletes (n = 40). The subjects underwent an extreme physical load test until total voluntary fatigue between 14:00 and 18:00 when the hormone levels are relatively stable. Blood was taken before the start (baseline), at the peak load (peak), and 30 min following completion of the exercise (recovery). The vital parameters, lactate levels, and blood levels of the 14 steroid hormones were recorded. The multivariate statistical analysis of the results revealed that all monitored hormone levels increased upon stress. Significant changes in steroid concentrations were detected at peak versus baseline, peak versus recovery, and at baseline versus recovery. The mineralocorticoid (including aldosterone and corticosterone), glucocorticoid (11-deoxycortisol and cortisol), and androgen (androstenedione, dehydroepiandrosterone, and dehydroepiandrosterone sulfate) pathways, as well as gonadal testosterone synthesis are activated simultaneously under extreme physical load. The profiling of adrenal and gonadal steroid biosynthesis in athletes may help the characterization of their loading capacity.Entities:
Keywords: load capacity; physical exercise; steroid
Year: 2022 PMID: 35208166 PMCID: PMC8878642 DOI: 10.3390/metabo12020091
Source DB: PubMed Journal: Metabolites ISSN: 2218-1989
Values of the physiological parameters and lactate concentrations as observed at the peak of the load (n = 40). Median values are shown along with the interquartile ranges (IQR) of heart rate (HR), lactate concentrations, relative maximal VO2 (rel.VO2 max), and respiratory quotient (RQ) in parentheses; bpm: number of beats per min.
| Physiological Parameters | Observed Median (IQR) |
|---|---|
| HR-baseline (bpm) | 68.5 (60.7–76.5) |
| HR-peak (bpm) | 187.0 (183.7–191.2) |
| HR-recovery (bpm) | 84.0 (74.5–90.5) |
| Lactate, baseline (mmol/L) | 0.92 (0.67–1.2) |
| Lactate, peak (mmol/L) | 10.9 (9.7–13.5) |
| Lactate, recovery (mmol/L) | 4.2 (3.1–4.8) |
| Rel.VO2 max. (mL/kg/min) | 51.3 (47.3–57.5) |
| Max. RQ | 1.4 (1.3–1.45) |
Figure 1Results of the exploratory multivariate analysis. (A) outcomes of the glog transformation and autoscaling of endogenous steroid concentrations; (B) score plot of the principal component analysis (PCA); (C) scree plot of the PCA; (D) result of the nonparametric analysis of variance; (E) heat map showing the results of Spearman’s correlation tests. ALDO: aldosterone; ADRN: androstenedione; CCON: corticosterone; CTOL: cortisol; CTON: cortisone; 11DC: 11-deoxycortisol; DHEA: dehydroepiandrosterone; DHES: dehydroepiandrosterone-sulfate; DHTT: dihydrotestosterone; OHPE: 17α-hydroxypregnenolone; OHPG: 17α-hydroxyprogesterone; TEST: testosterone.
Nonparametric univariate statistical comparison of the endogenous steroid concentrations measured at baseline, at the peak of the load, and during the recovery phase. Median values are shown along with the interquartile ranges (IQR), p-values, and the direction of changes in parentheses. Statistically significant changes in the values of the analytes are indicated by displaying the p-value in bold. ALDO: aldosterone; ADRN: androstenedione; CCON: corticosterone; CTOL: cortisol; CTON: cortisone; 11DC: 11-deoxycortisol; DHEA: dehydroepiandrosterone; DHES: dehydroepiandrosterone-sulfate; DHTT: dihydrotestosterone; OHPE: 17α-hydroxypregnenolone; OHPG: 17α-hydroxyprogesterone; TEST: testosterone; TEST/CTOL: testosterone–cortisol ratio; DHEA/CTOL: de dehydroepiandrosterone–cortisol ratio; CCON/CTOL: corticosterone-cortisol ratio; CCON/DHEA: corticosterone-dehydroepiandrosterone ratio; ↑: increase, ↓: decrease, -: no response.
| Baseline-Peak | Baseline-Recovery | Peak-Recovery | Median (IQR) (pmol/mL) | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Response | Response | Response | Baseline | Peak | Recovery | ||||
| ALDO | ↑ |
|
|
|
|
| 0.08 (0.08–0.10) | 0.14 (0.08–0.32) | 0.18 (0.08–0.40) |
| ADRN | ↑ |
|
|
|
| 0.342 | 1.9 (1.1–2.7) | 2.3 (1.4–3.2) | 2.4 (1.7–3.4) |
| DHEA | - | 0.114 |
|
|
|
| 10.3 (5.4–14.9) | 11.7 (7.9–18.3) | 18.7 (12.0–28.7) |
| DHES | - | 0.114 |
|
|
|
| 6268 (5393–8622) | 6702 (5895–9118) | 6635 (5827–9348) |
| DC11 | - | 0.075 |
|
|
| 0.758 | 0.14 (0.14–0.96) | 0.32 (0.14–0.15) | 0.46 (0.14–1.22) |
| OHPE | - | 0.110 |
|
|
|
| 2.3 (1.7–4.8) | 3.2 (1.9–5.2) | 5.2 (1.9–8.5) |
| OHPG | ↑ |
|
| 0.952 |
|
| 1.9 (0.0–5.5) | 2.5 (0.0–7.6) | 1.8 (0.0–5.2) |
| CCON | - | 0.304 |
|
|
|
| 9.5 (5.8–14.8) | 10.7 (5.3–20.1) | 26.9 (18.3–34.9) |
| CTOL | - | 0.829 |
|
|
|
| 404 (325–484) | 387 (293–483) | 504 (415–567) |
| CTON | ↑ |
|
|
|
|
| 82.2 (66.1–92.2) | 100.2 (80.1–116.6) | 84.4 (75.4–106.8) |
| TEST | ↑ |
|
|
|
|
| 19.8 (17.3–23.4) | 5.1 (20.5–30.1) | 21.9 (17.4–25.6) |
| DHTT | ↑ |
|
|
|
| 0.077 | 2.3 (1.5–3.7) | 2.6 (1.7–3.9) | 2.6 (1.6–4.0) |
| TEST/CTOL | ↑ |
|
|
|
|
| 0.05 (0.04–0.06) | 0.06 (0.05–0.09) | 0.04 (0.04–0.06) |
| DHEA/CTOL | ↑ |
|
|
|
|
| 0.03 (0.02–0.04) | 0.04 (0.02–0.04) | 0.04 (0.02–0.05) |
| CCON/CTOL | - | 0.265 |
|
|
|
| 0.02 (0.02–0.04) | 0.03 (0.02–0.04) | 0.05 (0.04–0.07) |
| CCON/DHEA | - | 0.166 |
| 0.197 |
|
| 0.91 (0.54–1.6) | 0.90 (0.49–1.3) | 1.4 (0.88–1.9) |